Upcoming Login Downtime

We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.

For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.

BioCentury
  • Company Profiles
  • Target Profiles
  • Product Profiles
Explore BCIQ profiles by entering a company name.

Eikonoklastes Therapeutics Inc.

Headquarters: Cincinnati, OH, United States of America
Year Founded: 2019
Status: Private

BioCentury | Jun 29, 2021
Deals

June 28 Quick Takes: STARs aligning for BeiGene trifecta; plus venture money for Neurona, Vita, Lyndra, Currus and Eikonoklastes 

Monday’s authorization to list on the Shanghai Stock Exchange’s STAR market sets BeiGene Ltd. (NASDAQ:BGNE; HKEX:6160) up to add its third listing, pending approval by China Securities
Items per page:
1 - 1 of 1